JanNovakMD
Gastroenterology • Buffalo, NYProfessor, Medicine, SUNY Buffalo School of Medicine & Biomedical
Dr. Novak is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
462 Grider St
Buffalo, NY 14215Phone+1 716-898-3391Fax+1 716-961-9911
Education & Training
University of Rochester Medical CenterResidency, Internal Medicine, 1972 - 1973
Jacobi Medical Center/Albert Einstein College of MedicineResidency, Internal Medicine, 1970 - 1972
Jacobs School of Medicine and Biomedical Sciences at the University at BuffaloClass of 1970
Certifications & Licensure
NY State Medical License 1971 - 2027
GA State Medical License 1977 - 1979
American Board of Internal Medicine Internal Medicine- American Board of Internal Medicine Gastroenterology
Awards, Honors, & Recognition
- Fellow (AGAF) American Gastroenterological Association, 2006
Publications & Presentations
PubMed
- 21 citationsPeriodontal disease is associated with increased gut colonization of pathogenic Haemophilus parainfluenzae in patients with Crohn's disease.Jiho Sohn, Lu Li, Lixia Zhang, Robert J Genco, Karen L Falkner
Cell Reports. 2023-02-28 - 22 citationsPorphyromonas gingivalis indirectly elicits intestinal inflammation by altering the gut microbiota and disrupting epithelial barrier function through IL9-producing CD4...Jiho Sohn, Lu Li, Lixia Zhang, Rajendra P Settem, Kiyonobu Honma
Molecular Oral Microbiology. 2022-04-01 - 21 citationsAutoantibodies Specific for Galactose-Deficient IgA1 in IgA Vasculitis With Nephritis.Hitoshi Suzuki, Zina Moldoveanu, Bruce A. Julian, Robert J. Wyatt, Jan Novak
Kidney International Reports. 2019-08-30
Grant Support
- Molecular Basis of Pathogenicity of IgA1-containing Immune ComplexesUNIVERSITY OF ALABAMA AT BIRMINGHAM2007–2028
- Defining the impact of glycan-microdomains of the HIV-1 Env glycan shieldUNIVERSITY OF ALABAMA AT BIRMINGHAM2021–2026
- Defining the impact of glycan-microdomains of the HIV-1 Env glycan shieldUNIVERSITY OF ALABAMA AT BIRMINGHAM2021–2026
- Defining the impact of glycan-microdomains of the HIV-1 Env glycan shieldUNIVERSITY OF ALABAMA AT BIRMINGHAM2021–2026
- Defining the impact of glycan-microdomains of the HIV-1 Env glycan shieldUNIVERSITY OF ALABAMA AT BIRMINGHAM2021–2026
- Pathogenic Autoantibodies with Specificity for Aberrant Glycoproteins: Assessment of a Therapeutic Target in an Autoimmune DiseaseUNIVERSITY OF ALABAMA AT BIRMINGHAM2020–2025
- Elucidating IgA nephropathy through Genetic Studies of IgA1 GlycosylationCOLUMBIA UNIVERSITY HEALTH SCIENCES2009–2025
Professional Memberships
- Fellow
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
